Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
VYVGART Inf Konz 400 mg/20ml Durchstf
Drug
Vyvgart, Solution à diluer pour perfusion
07.15.0. – immunosuppressants
HAM – Human medicine
KOINF – Concentrate for solution for infusion
BT – biological medicines
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
10/3/2024
10/2/2029
Dosage strength
Vyvgart 400 mg/20ml, solution à diluer pour perfusion
Vyvgart est indiqué en association au traitement standard chez les patients adultes atteints de myasthénie auto-immune généralisée et présentant des anticorps anti-récepteurs de l’acétylcholine (RACh).
01
Z – approved
Package
7680692860019
No information made available
A/R – Authorised / referenced
1 vial(s)
001
Z – approved
Declaration
Component
400 mg efgartigimodum alfa
natrii dihydrogenophosphas monohydricus
dinatrii phosphas
natrii chloridum
arginini hydrochloridum
polysorbatum 80
aqua ad iniectabile
67.2 mg natrium
dinatrii phosphas
natrii chloridum
arginini hydrochloridum
polysorbatum 80
aqua ad iniectabile
67.2 mg natrium
Authorisation holder
7601009128554
argenx Switzerland SA
1202 Genève (GE)
1202 Genève (GE)
Date of revision of the text
11/12/2024
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.